Rachel Warren
Family · Jacksonville, FLNPI 1356071658
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 218 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by UCB, Inc. at 24.0% of the total. Among family clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 218 payments — averaging $21.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$1K
- AbbVie$548
- Sun Pharmaceutical Industries Inc.$495
- Regeneron Healthcare Solutions, Inc.$466
- Incyte Corporation$379
- Almirall LLC$341
- plus $1K from 15 others
What the payments were for
- Food & beverage$4,739100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 55 | $1,139 |
| AbbVie | 16 | $548 |
| Sun Pharmaceutical Industries Inc. | 23 | $495 |
| Regeneron Healthcare Solutions, Inc. | 22 | $466 |
| Incyte Corporation | 13 | $379 |
| Almirall LLC | 19 | $341 |
| Arcutis Biotherapeutics, Inc. | 19 | $314 |
| Mayne Pharma Commercial LLC | 17 | $221 |
| Organogenesis Inc. | 4 | $116 |
| Lilly USA, LLC | 5 | $110 |
| Galderma Laboratories, L.p. | 3 | $101 |
| Amgen | 4 | $96 |
| Novartis | 4 | $80 |
| Sanofi | 2 | $63 |
| Genentech USA, Inc. | 2 | $54 |
| E.r. Squibb & Sons, L.L.C. | 2 | $46 |
| LEO Pharma Inc. | 2 | $45 |
| Boehringer Ingelheim | 2 | $38 |
| Team 1, LLC | 2 | $37 |
| Verrica Pharmaceuticals Inc. | 1 | $26 |
| Biowound Solutions, Inc. | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Bimzelx$257
- OPZELURA$245
- DUPIXENT$132
- Winlevi$122
- ABSORICA LD$122
How this compares
$4,739 in reported general payments places this provider in the 90th percentile of 14,618 family providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 16 | $1,660 |
| Ketoconazole | 98 | $1,154 |
| Doxycycline Hyclate | 29 | $527 |
| Triamcinolone Acetonide | 42 | $363 |
| Mupirocin | 44 | $312 |
| Hydrocortisone | 44 | $208 |
Paid to pharmacies, not to this prescriber.
Other family in Jacksonville
- Leighanne MeadeJacksonville$98K
- Jori TaylorJacksonville$48K
- Macy SaundersJacksonville$30K
- Amy KadlubowskiJacksonville$29K
- Lewis HarringtonTampa$954K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
- Deena RodneyMaitland$323K
- Yamila MelendezMiami$212K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.